Literature DB >> 29038197

Obstructive coronary artery disease in patient with acute thrombotic thrombocytopenic purpura.

Szymon L Wiernek1, Xuming Dai1.   

Abstract

Thrombotic thrombocytopenic purpura (TTP) affects essentially all organ systems. Myocardial injury in TTP is often attributed to microthrombi formation. We present the first case report in the literature of an acute TTP patient with concomitant obstructive coronary artery disease (CAD) and acute myocardial infarction who underwent successful percutaneous coronary intervention (PCI). A 70-year-old female patient who was diagnosed with acute TTP required plasma exchange. The patient also experienced episodes of angina pectoris, elevated cardiac enzymes and global ST segment depressions on ECG. A subsequent non-invasive ischaemia workup revealed significant ischaemia. Coronary angiography revealed obstructive CAD in her right coronary artery, requiring PCI with a bare metal stent placement and dual antiplatelet therapy. The patient tolerated antiplatelet therapy well. At 6 months of follow-up, she had no recurrent angina. This case highlights the potential co-existence of obstructive CAD and acute TTP requiring careful differential diagnosis and treatment. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cardiovascular medicine; haematology (incl blood transfusion); interventional cardiology

Mesh:

Year:  2017        PMID: 29038197      PMCID: PMC5652628          DOI: 10.1136/bcr-2017-222437

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Acute myocardial infarction in thrombotic microangiopathies--clinical characteristics, risk factors and outcome.

Authors:  Daniel Patschan; Oliver Witzke; Ulrich Dührsen; Raimund Erbel; Thomas Philipp; Stefan Herget-Rosenthal
Journal:  Nephrol Dial Transplant       Date:  2006-03-30       Impact factor: 5.992

2.  A rare cause of acute myocardial infarction: thrombotic thrombocytopenic purpura.

Authors:  Hee Hwa Ho; Robert Minutello; Nickolas Juliano; Shing Chiu Wong
Journal:  Int J Cardiol       Date:  2007-12-18       Impact factor: 4.164

3.  ST-segment elevation myocardial infarction treated with thrombolytic therapy in a patient with thrombotic thrombocytopenic purpura.

Authors:  Jacob A Doll; Jacob P Kelly
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

Review 4.  Thrombotic thrombocytopenic purpura: recognition and management.

Authors:  Joseph E Kiss
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

5.  Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center.

Authors:  Y Benhamou; P-Y Boelle; B Baudin; S Ederhy; J Gras; L Galicier; E Azoulay; F Provôt; E Maury; F Pène; J-P Mira; A Wynckel; C Presne; P Poullin; J-M Halimi; Y Delmas; T Kanouni; A Seguin; C Mousson; A Servais; D Bordessoule; P Perez; M Hamidou; A Cohen; A Veyradier; P Coppo
Journal:  J Thromb Haemost       Date:  2014-12-18       Impact factor: 5.824

Review 6.  Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR).

Authors:  Sony Jacob; Brianne L Dunn; Zaina P Qureshi; Nicholas Bandarenko; Hau C Kwaan; Dilip K Pandey; June M McKoy; Sara E Barnato; Jeffrey L Winters; John F Cursio; Ivy Weiss; Thomas J Raife; Patricia M Carey; Ravindra Sarode; Joseph E Kiss; Constance Danielson; Thomas L Ortel; William F Clark; Gail Rock; Masanori Matsumoto; Yoshihiro Fujimura; X Long Zheng; Hao Chen; Fei Chen; John M Armstrong; Dennis W Raisch; Charles L Bennett
Journal:  Semin Thromb Hemost       Date:  2012-10-30       Impact factor: 4.180

7.  Cardiac injury is a common postmortem finding in thrombotic thrombocytopenic purpura patients: is empiric cardiac monitoring and protection needed?

Authors:  Larry Nichols; Aaron Berg; Marian A Rollins-Raval; Jay S Raval
Journal:  Ther Apher Dial       Date:  2014-09-04       Impact factor: 1.762

8.  Thrombotic thrombocytopenic purpura: combined treatment with plasmapheresis and antiplatelet agents.

Authors:  T J Myers; C J Wakem; E D Ball; S J Tremont
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.